Marin: Ninth Participant Treated; One More Enrolled

On May 9, 2016, the ninth participant was treated in our ongoing study of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness in Marin, Calif. The 10th participant was enrolled on May 12 (after the previous 10th participant relocated and dropped out). Led by Principal Investigator Phil Wolfson, M.D., with co-therapist Julane Andries, LMFT, this study is gathering preliminary data about the safety and efficacy of MDMA-assisted psychotherapy for anxiety in 18 subjects diagnosed with a life-threatening illness. “I can live my life right now,” explains study participant Wendy Donner. “That is such a gift for me.”